Late-stage tertiary lymphoid structures in hepatocellular carcinoma treated with neoadjuvant immune checkpoint blockade
Daniel Shu(University of Maryland, Baltimore), Mark Yarchoan(Sidney Kimmel Comprehensive Cancer Center), Lars Engle(University of Tulsa), Qingfeng Zhu(University of Science and Technology of China), Emma Kartalia, Kabeer Munjal, Jennifer N. Durham(Sidney Kimmel Comprehensive Cancer Center), Xuan Yuan(Johns Hopkins University), James W. Leatherman(Hennepin County), Marina Baretti(Sidney Kimmel Comprehensive Cancer Center), Elana J. Fertig(Bloomberg (United States)), Tamara Y. Lopez‐Vidal, Kathryn L. Howe(University Health Network), Daniel A. Laheru(Bloomberg (United States)), Janis M. Taube(Bloomberg (United States)), Larisa Danilova, Elizabeth M. Jaffee(Bloomberg (United States)), A Hernandez(University of Michigan), Dimitrios N. Sidiropoulos(Johns Hopkins University), Elisabeth Coyne, George Mo, Aleksandra Ogurtsova(Johns Hopkins University), Julia Deutsch, Andrew H. Girgis, Jonathan H. Sunshine, Kayla J. Bendinelli, Luciane T. Kagohara(Bloomberg (United States)), Hao Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jeong Eon Lee(Seoul National University), William Ho(Baker Heart and Diabetes Institute), Sung Jae Shin(Yonsei University), Qi Huang, Robert A. Anders(Sidney Kimmel Comprehensive Cancer Center), S. L. Mitchell(Beth Israel Deaconess Medical Center), J P Montagne, Albert Huff, Noorin Zaidi, R. Johnston, Daniel J. Zabransky(Bloomberg (United States))
Cited by 0
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k